Adjuvant chemotherapy is associated with improved survival for late-stage salivary squamous cell carcinoma
The Laryngoscope Aug 31, 2018
Cheraghlou S, et al. - Authors ascertained the outcomes related to the use of adjuvant radiotherapy and chemoradiotherapy in the treatment of early- and late-stage salivary squamous cell carcinoma (SCC). Findings suggested probable improved long-term survival with the addition of chemotherapy to the adjuvant therapy of late-stage patients with salivary SCC. Patient outcomes may also be improved with the expanded use of adjuvant therapy for early-stage disease.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries